Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is InterMedical Care and Lab Hospital PCL EV-to-EBIT?
InterMedical Care and Lab Hospital PCLBKK:IMH -8.37%65 EV-to-EBIT is 180.40 as of Aug. 29, 2026, which is 2613% above its 10-year median of 6.65. GuruFocus rates BKK:IMH with a GF Score™ of 65/100 and a GF Value™ of ฿4.17 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 480 Healthcare Providers & Services companies, InterMedical Care and Lab Hospital PCL ranks worse than 96.67% on this metric.
BKK:IMH's EV-to-EBIT is ranked worse than 96.67% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs BKK:IMH: 180.40
InterMedical Care and Lab Hospital PCL (BKK:IMH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
InterMedical Care and Lab Hospital PCL's Enterprise Value for the quarter that ended in Jun. 2026 was ฿1,818.7 Mil.
InterMedical Care and Lab Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿11.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL EV-to-EBIT Related Terms
InterMedical Care and Lab Hospital PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL EV-to-EBIT Chart
InterMedical Care and Lab Hospital PCL Annual Data
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's EV-to-EBIT falls into.
InterMedical Care and Lab Hospital PCL's current Enterprise Value is ฿1,979.9 Mil.
InterMedical Care and Lab Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿11.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL (BKK:IMH) has a EV-to-EBIT of 180.40 as of Aug. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. This is 2613% above median its historical median of 6.65. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #464 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 96.7%.
Is InterMedical Care and Lab Hospital PCL's EV-to-EBIT too high?
InterMedical Care and Lab Hospital PCL's current EV-to-EBIT of 180.40 is 2613% above median its 10-year median of 6.65. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. InterMedical Care and Lab Hospital PCL's value of 180.40 is 1043.2% above this industry median. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #464 out of 480 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #464 out of 480 companies for EV-to-EBIT. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median EV-to-EBIT is 15.78. InterMedical Care and Lab Hospital PCL's value of 180.40 is 1043.2% above this benchmark. While the company's 10-year median is 6.65 vs. the industry median of 15.78, InterMedical Care and Lab Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InterMedical Care and Lab Hospital PCL's current EV-to-EBIT of 180.40 is 1043.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current EV-to-EBIT is 180.40, which is 2613% above median its own 10-year median of 6.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿4.17, compared to a current price of ฿3.72 — trading 10.8% below its estimated fair value. The current EV-to-EBIT is 180.40, which is 2613% above median its 10-year median of 6.65 and 1043.2% above the Healthcare Providers & Services industry median of 15.78. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH), the current EV-to-EBIT is 180.40 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.72 is trading 10.8% below its estimated GF Value™ of ฿4.17.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:IMH:
EV-to-EBIT: 180.40 (2613% above median its 10-year median of 6.65)
GF Value™: ฿4.17 vs. price of ฿3.72 (10.8% below fair value)
Industry Position: 1043.2% above the Healthcare Providers & Services median (#464 of 480)
No single metric tells the full story. See the BKK:IMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
65GF Score
Get the complete analysis for BKK:IMH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH has been successfully added to your 
